The Needle-Free Future
Vaxxas' HD-MAP technology uses a patch with thousands of vaccine-coated microprojections that is applied to the skin for a few seconds to efficiently deliver vaccine to the abundant immune cells immediately below the skin surface.
Empowered To Do More
Vaxxas' approach shifts the value paradigm of vaccines. Vaxxas' HD-MAP platform has been:
- Productized for commercial use
- Validated in human clinical studies
- Designed for manufacture at scale